Clinical Trials Browser

OTHER × efatutazone × Plasma cell × Clear all

NCT01504490 2017-02-14

Phase I Study of CS-7017 and Bexarotene

Phase 1 Terminated

LymphoidPlasma cell

Lymphoma, Multiple Myeloma